Close

Analyst Ratings for Horizon Therapeutics (HZNP)

HZNP Rating Summary

HZNP Price Target Summary

* Over Last 12-Mos
  |   Expand Research on HZNP
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $109.00 (-0.5%) * Over Last 12-Mos
Rating Score: 5.2 / 10   Percentile Rank: 55%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/13/2022 SVB Leerink Joseph P. Schwartz Downgrade Market Perform
(Outperform)
N/A
(N/A)
112.36
(109.60)
-2.46% Details
12/13/2022 Guggenheim Yatin Suneja Downgrade Neutral
(Buy)
116.50
(98.00)
112.36
(109.60)
-2.46% Details
Like HZNP Ratings? Also take a look at HPR, AMGN, SNY, JNJ

HZNP Ratings News